Literature DB >> 31177107

Radiation-induced Vascular Damage and the Impact on the Treatment Outcome of Stereotactic Body Radiotherapy.

Emely Kjellsson Lindblom1, Susanta Hui2, Jamison Brooks2,3, Alexandru Dasu4,5, Maciej Kujawski6, Iuliana Toma-Dasu7,8.   

Abstract

BACKGROUND/AIM: The aim of this study was to investigate radiation-induced tumour vascular damage and its impact thereof on the outcome of stereotactic body radiotherapy (SBRT).
MATERIALS AND METHODS: Vessel densities in animal tumours before and after a single dose of 20 Gy were quantified and used as input for simulations of three-dimensional tumours with heterogeneous oxygenation. SBRT treatments of the modelled tumours in 1-8 fractions were simulated. The impact of vessel collapse on the outcome of SBRT was investigated by calculating tumour control probability (TCP) and the dose required to obtain a TCP of 50% (D50).
RESULTS: A radiation-induced increase of acute hypoxia in tumours during SBRT treatment could be simulated based on the experimental data. The D50 values for these tumours were higher than for the simulated tumours without vessel collapse.
CONCLUSION: The vascular changes after high doses of radiation could compromise the outcome of SBRT by increasing tumour hypoxia. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Hypoxia; SBRT; TCP; radiation-induced vascular damage; stereotactic body radiotherapy; tumour control probability; tumour oxygenation

Mesh:

Year:  2019        PMID: 31177107      PMCID: PMC8881796          DOI: 10.21873/anticanres.13398

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  23 in total

1.  Red shell: defining a high-risk zone of normal tissue damage in stereotactic body radiation therapy.

Authors:  Jun Yang; Jack F Fowler; John P Lamond; Rachelle Lanciano; Jing Feng; Luther W Brady
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-17       Impact factor: 7.038

Review 2.  The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?

Authors:  J Martin Brown; David J Carlson; David J Brenner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

3.  Engaging the vascular component of the tumor response.

Authors:  Zvi Fuks; Richard Kolesnick
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

4.  To fractionate or not to fractionate? That is the question for the radiosurgery of hypoxic tumors.

Authors:  Iuliana Toma-Dasu; Helena Sandström; Pierre Barsoum; Alexandru Dasu
Journal:  J Neurosurg       Date:  2014-12       Impact factor: 5.115

5.  Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm.

Authors:  Atsuya Takeda; Naoko Sanuki; Etsuo Kunieda; Toshio Ohashi; Yohei Oku; Toshiaki Takeda; Naoyuki Shigematsu; Atsushi Kubo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-05       Impact factor: 7.038

6.  Tumor response to radiotherapy regulated by endothelial cell apoptosis.

Authors:  Monica Garcia-Barros; Francois Paris; Carlos Cordon-Cardo; David Lyden; Shahin Rafii; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Science       Date:  2003-05-16       Impact factor: 47.728

7.  Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography.

Authors:  W J Koh; K S Bergman; J S Rasey; L M Peterson; M L Evans; M M Graham; J R Grierson; K L Lindsley; T K Lewellen; K A Krohn
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-09-30       Impact factor: 7.038

8.  Globally optimal stitching of tiled 3D microscopic image acquisitions.

Authors:  Stephan Preibisch; Stephan Saalfeld; Pavel Tomancak
Journal:  Bioinformatics       Date:  2009-04-03       Impact factor: 6.937

Review 9.  Hypoxia in Head and Neck Tumors: Characteristics and Development during Therapy.

Authors:  Martin-Immanuel Bittner; Anca-Ligia Grosu
Journal:  Front Oncol       Date:  2013-08-28       Impact factor: 6.244

Review 10.  Modelling tumour oxygenation, reoxygenation and implications on treatment outcome.

Authors:  Iuliana Toma-Dasu; Alexandru Dasu
Journal:  Comput Math Methods Med       Date:  2013-01-14       Impact factor: 2.238

View more
  5 in total

1.  Orchestrated delivery of PTH [1-34] followed by zoledronic acid prevents radiotherapy-induced bone loss but does not abrogate marrow damage.

Authors:  Ashley R Sweeney-Ambros; Amy E Biggs; Nicholas D Zimmerman; Kenneth A Mann; Timothy A Damron; Megan E Oest
Journal:  J Orthop Res       Date:  2022-03-10       Impact factor: 3.102

2.  Automated in vivo Assessment of Vascular Response to Radiation using a Hybrid Theranostic X-ray Irradiator/Fluorescence Molecular Imaging System.

Authors:  Farouk Nouizi; Jamison Brooks; Darren M Zuro; Srideshikan Sargur Madabushi; Dayson Moreira; Marcin Kortylewski; Jerry Froelich; Lydia M Su; Gultekin Gulsen; Susanta K Hui
Journal:  IEEE Access       Date:  2020-05-15       Impact factor: 3.367

3.  Thyroid Gland Flap for Minimally Invasive Reconstructive Head and Neck Surgery.

Authors:  Tetsuya Ogawa; Daisuke Inukai; Hiroki Okamoto; Rui Sano; Syunpei Yamanaka; Toyonori Tsuzuki; Munekazu Naito
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-12-17

Review 4.  Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases.

Authors:  Enrique Gutiérrez; Irving Sánchez; Omar Díaz; Adrián Valles; Ricardo Balderrama; Jesús Fuentes; Brenda Lara; Cipatli Olimón; Víctor Ruiz; José Rodríguez; Luis H Bayardo; Matthew Chan; Conrad J Villafuerte; Jerusha Padayachee; Alexander Sun
Journal:  Curr Oncol       Date:  2021-07-15       Impact factor: 3.677

5.  A novel larynx-preserving pharyngectomy technique using a thyroid gland flap after chemoradiotherapy.

Authors:  Tetsuya Ogawa; Hiroki Okamoto; Daisuke Inukai; Rui Sano; Nobuyuki Katahira; Syunpei Yamanaka; Kinga Yo; Taichi Kan; Hiromi Ueda
Journal:  Clin Case Rep       Date:  2019-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.